leisure time -WSS

leisure time

author：leisure time 2025-08-25 07:30:20 - browse：39

Editor’s note: A recording of the event is embedded below.

Now that biosimilar versions of Humira are starting to arrive, what happens next? Will this finally prove the case that biosimilars can deliver on big health care savings? What key signals will indicate how biosimilars might be prescribed, or paid for?

Let’s dive in and discuss what to watch in the months ahead.

Speakers:

Alex Brill, CEO, Matrix Global Advisors
Chris Brown, managing partner and co-founder, Integrity Rx Partners
Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)
Thomas Newcomer, head of U.S. market access, Samsung Bioepis (sponsor speaker)

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Medical devices makers are asking for forgiveness, not permission

focus

WSS

How a scoliosis diagnosis changed the life of one young dancer

Antibiotic resistance and the global rise in human conflict

Medicare Advantage insurers pressure Biden for bigger payments

6 surprising facts about sugar

Pfizer, Moderna say biotech, pharma drug development is a sprint

Cancer, immunology, HIV research ensnared in fetal tissue politics

knowledge

leisure time

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

How one medical school became remarkably diverse

White House finalizes ITC's import ban of latest Apple Watches

As demand for Covid shots wanes, Moderna seeks its next success

White House finalizes ITC's import ban of latest Apple Watches

As demand for Covid shots wanes, Moderna seeks its next success

New weight loss drugs work. But how can they best be used?

In age of alternative facts, a scholarly course on calling out crap

Testing GLP

hotspot

Chronically ill young patients struggle to find fertility info

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Burning questions for the 2024 JPM Healthcare Conference

Antibiotic resistance and the global rise in human conflict

'Patient friction coefficient' can gauge a clinical trial's patient burden

Why psychiatrists like me stop taking insurance

Wikipedia

focus

entertainment

entertainment